Suzana M Vieira

Suzana M Vieira

Auto-generated profile, based on publicly available information

Suzana M Vieira

Laboratório de Endocrinologia Celular e Molecular (LIM-25), Faculdade de Medicina da Universidade de São Paulo, 01246-903 São Paulo-SP, Brazil

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2011 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
SVSuzana M Vieira
Suzana M Vieira
MMMaria B Monteiro
Maria B Monteiro
TMTatiana Marques
Tatiana Marques
ALAna M Luna
Ana M Luna
MFMaria A Fortes
Maria A Fortes
MCMaria Lucia Correa-Giannella
Maria Lucia Correa-Giannella
Background: Oxidative stress is recognized as a major pathogenic factor of cellular damage caused by hyperglycemia. NOX/NADPH oxidases generate reactive oxygen species and NOX1, NOX2 and NOX4 isoforms are expressed in kidney and require association with subunit p22phox (encoded by theCYBAgene). Increased expression of p22phox was described in animal models of diabetic nephropathy. In the opposite direction, glutathione is one of the main endogenous antioxidants whose plasmatic concentrations were reported to be reduced in diabetes patients. The aim of the present investigation was to test whether functional single nucleotide polymorphisms (SNPs) in genes involved in the generation of NADPH-dependent O2•-(-675 T → A inCYBA, unregistered) and in glutathione metabolism (-129 C → T inGCLC[rs17883901] and -65 T → C inGPX3[rs8177412]) confer susceptibility to renal disease in type 1 diabetes patients.Methods: 401 patients were sorted into two groups according to the presence (n = 104) or absence (n = 196) of overt diabetic nephropathy or according to glomerular filtration rate (GFR) estimated by Modification of Diet in Renal Disease (MDRD) equation: ≥ 60 mL (n = 265) or < 60 mL/min/1.73 m2(n = 136) and were genotyped.Results: No differences were found in the frequency of genotypes between diabetic and non-diabetic subjects. The frequency of GFR < 60 mL/min was significantly lower in the group of patients carryingCYBAgenotypes T/A+A/A (18.7%) than in the group carrying the T/T genotype (35.3%) (P = 0.0143) and the frequency of GFR < 60 mL/min was significantly higher in the group of patients carryingGCLCgenotypes C/T+T/T (47.1%) than in the group carrying the C/C genotype (31.1%) (p= 0.0082). Logistic regression analysis identified the presence of at least one A allele of theCYBASNP as an independent protection factor against decreased GFR (OR = 0.38, CI95% 0.14-0.88,p= 0.0354) and the presence of at least one T allele of theGCLCrs17883901 SNP as an independent risk factor for decreased GFR (OR = 2.40, CI95% 1.27-4.56,p= 0.0068).Conclusions: The functional SNPsCYBA-675 T → A andGCLCrs17883901, probably associated with cellular redox imbalances, modulate the risk for renal disease in the studied population of type 1 diabetes patients and require validation in additional cohorts.